Identification Module
The Identification Module contains basic identifying information about the clinical trial, including the NCT ID, brief title, official title, acronym, organization study ID information, and organization details. This module provides essential identifiers for the trial.
Identification Module path is as follows:
Study -> Protocol Section -> Identification Module
Identification Module
Ignite Creation Date:
2025-12-24 @ 4:21 PM
Ignite Modification Date:
2025-12-24 @ 4:21 PM
NCT ID:
NCT01077466
Brief Title:
Natalizumab Treatment of Progressive Multiple Sclerosis
Official Title:
Natalizumab Treatment of Progressive Multiple Sclerosis
Acronym:
NAPMS
Study:
NCT01077466
Protocol Section:
NCT01077466